60029-23-4 CXT50CA7II Trimorfamid Formamide, N-(2,2,2-trichloro-1-(morpholinyl)ethyl)- Formamide, N-(2,2,2-trichloro-1-(4-morpholinyl)ethyl)- N-(2,2,2-Trichloro-1-morpholinoethyl)formamide Trimorphamide BRN 0982511 CCRIS 3702 EINECS 262-028-1 Fademorf EK 20 Fademorf ZK 20 N-(1-Formamido-2,2,2-trichloretyl)morfolin [Czech] Trimorfamide Trimorphamid VUAgT 866 VUAgT 866/72 N-(1-Formamido-2,2,2-trichloretyl)morfolin UNII-CXT50CA7II CAS 60029-23-4

Purity 97%+In StockPharmaceutical Standards
CAS No.60029-23-4
Molecular FormulaC7H11Cl3N2O2
Molecular Weight261.53 g/mol
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

60029-23-4 CXT50CA7II Trimorfamid Formamide, N-(2,2,2-trichloro-1-(morpholinyl)ethyl)- Formamide, N-(2,2,2-trichloro-1-(4-morpholinyl)ethyl)- N-(2,2,2-Trichloro-1-morpholinoethyl)formamide Trimorphamide BRN 0982511 CCRIS 3702 EINECS 262-028-1 Fademorf EK 20 Fademorf ZK 20 N-(1-Formamido-2,2,2-trichloretyl)morfolin [Czech] Trimorfamide Trimorphamid VUAgT 866 VUAgT 866/72 N-(1-Formamido-2,2,2-trichloretyl)morfolin UNII-CXT50CA7II CAS 60029-23-4 chemical structure

Description

The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.

60029-23-4 CXT50CA7II Trimorfamid Formamide, N-(2,2,2-trichloro-1-(morpholinyl)ethyl)- Formamide, N-(2,2,2-trichloro-1-(4-morpholinyl)ethyl)- N-(2,2,2-Trichloro-1-morpholinoethyl)formamide Trimorphamide BRN 0982511 CCRIS 3702 EINECS 262-028-1 Fademorf EK 20 Fademorf ZK 20 N-(1-Formamido-2,2,2-trichloretyl)morfolin [Czech] Trimorfamide Trimorphamid VUAgT 866 VUAgT 866/72 N-(1-Formamido-2,2,2-trichloretyl)morfolin UNII-CXT50CA7II (CAS 60029-23-4), molecular formula C7H11Cl3N2O2 and molecular weight 261.53 g/mol, is a CATO reference standard with documented purity and traceability.

The molecular framework of 60029-23-4 CXT50CA7II Trimorfamid Formamide, N-(2,2,2-trichloro-1-(morpholinyl)ethyl)- Formamide, N-(2,2,2-trichloro-1-(4-morpholinyl)ethyl)- N-(2,2,2-Trichloro-1-morpholinoethyl)formamide Trimorphamide BRN 0982511 CCRIS 3702 EINECS 262-028-1 Fademorf EK 20 Fademorf ZK 20 N-(1-Formamido-2,2,2-trichloretyl)morfolin [Czech] Trimorfamide Trimorphamid VUAgT 866 VUAgT 866/72 N-(1-Formamido-2,2,2-trichloretyl)morfolin UNII-CXT50CA7II (C7H11Cl3N2O2) is characterized by an amide group, a carboxylic acid group, a hydroxyl group, an ether linkage, chlorine substitution. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

Physical & Chemical Properties

Molecular FormulaC7H11Cl3N2O2
Molecular Weight261.53 g/mol
Purity97%+
StorageStore at 2-8°C, protect from light, keep sealed and dry, keep tightly closed to prevent evaporation
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityLight-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions
Degree of Unsaturation (DBE)2.0
CAS Registry Year (est.)1974
Halogen ContentCl-containing
Nitrogen Atoms2

Recommended Standards

Why CATO?